ArticleWorld journal of surgical oncology2026
Days alive and out of hospital after video-assisted thoracoscopic lobectomy or segmentectomy for lung cancer: a prospective Chinese cohort study.
Article in World journal of surgical oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
- Time toxicity in cancer care: a systematic review of definitions and measurement methods.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026Pooled it
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
objectivesThis study aimed to provide Chinese data on Days Alive and Out of Hospital (DAOH) following video-assisted thoracoscopic surgery (VATS) lobectomy or segmentectomy.
methodsThe analyzed data was derived from a prospective cohort study. Consecutive patients who underwent either VATS lobectomy or segmentectomy from April 2021 to July 2022 were included. The primary outcome was DAOH within the first 90 days postoperatively (DAOH90). The secondary outcomes were identifying the predominant complications and reasons for readmission during the DAOH90. Additionally, we utilized multivariate logistic regression to identify factors independently associated with decreased DAOH90.
resultsA total of 919 primary lung cancer patients were included. The median DAOH90 was 86 days (IQR, 85–87). The predominant postoperative complications within postoperative 90 days (POD90) were pneumonia (22.5%), pleural pneumothorax (15.8%), incision dehiscence (13.8%) and pleural effusion (12.8%). The primary causes of readmission in POD90 included pleural effusion (10 cases), pneumonia (7 cases), and incision dehiscence (4 cases). Age (P < .001), operative time (P < .001), operative bleeding (P = .023) and multiportal VATS (compared with robot-assisted VATS) were independently associated with decreased DAOH90.
conclusionsIn this study, the median DAOH90 following VATS lobectomy or segmentectomy was 86 days. Advanced age, longer surgical duration, more operative bleeding and multiportal VATS may be independent risk factors for “low DAOH90.”
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.